Dr. Khomtchouk’s research group is pioneering the field of cardioinformatics, working at the nexus of bioinformatics and precision cardiology. Its researchers are working toward integrating computational biology and AI/machine learning-based approaches to illuminate novel cardio-(vascular/renal/metabolic) biology and enable new therapeutics.

The lab’s principal research focus is on engineering database technologies that provide powerful query and browsing interfaces between biomedical data and user. Its primary goal is to enable computationally derived therapeutics in heart disease and its associated renal and metabolic co-morbidities (e.g., chronic kidney disease and type 2 diabetes). These collectively comprise the leading cause of death worldwide and disproportionally affect older demographics and historically underrepresented minority populations.

Dr. Khomtchouk’s research program is nationally recognized by the American Heart Association (AHA). He serves on the editorial board of “Circulation: Genomic and